Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Paricalcitol Injection

Approval Number

国药准字H20213094

Company青岛国信制药有限公司

Registration Date

February 2, 2021

Drug Information

Generic Name

帕立骨化醇注射液

Dosage Form

注射剂

Strength

1ml:5μg

Drug Type

化学药品

Registration Date

February 2, 2021

Company Information

Applicant Company

Company Name青岛国信制药有限公司

Company Address

青岛经济技术开发区团结路3601号

Manufacturing Company

Company Name北京泰德制药股份有限公司

Company Address

北京市北京经济技术开发区荣京东街8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

帕立骨化醇注射液 - NMPA 批准文号 | MedPath